Ikarian Capital, LLC My Md Pharmaceuticals, Inc. Transaction History

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$2.0 - $4.78 $100,600 - $240,434
-50,300 Reduced 38.28%
81,089 $176,000
Q1 2022

May 13, 2022
BUY
$3.34 - $6.05 $24,679 - $44,703
7,389 Added 5.96%
131,389 $612,000
Q4 2021

Feb 14, 2022
BUY
$5.46 - $9.69 $677,040 - $1.2 Million
124,000 New
124,000 $751,000

Others Institutions Holding MYMD

# of Institutions
2
Shares Held
30.2K
Call Options Held
0
Put Options Held
0
View Full List

About MyMD Pharmaceuticals, Inc.

MYMD Quotes by TradingView
  • Ticker MYMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,470,000
  • Market Cap $67.5M
  • Description
  • MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...
More about MYMD
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email